Dizal Pharmaceutical Hits Day High with Strong 3.72% Intraday Surge

Dizal (Jiangsu) Pharmaceutical Co., Ltd. has experienced a notable uptick in its stock performance, gaining 3.72% on June 18, 2026. The stock reached an intraday high of CNY 38.96, marking a significant moment in its trading activity. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 0.43% on the same day. Over the past week, Dizal has shown a modest increase of 2.29%, while its performance over the last month reflects a decline of 25.3%. In the longer term, the stock has faced challenges, with a year-to-date drop of 34.1% and a one-year performance down by 37.66%. Despite these setbacks, the company has managed to generate a return of 1.74% over the past three years. Dizal operates within the miscellaneous industry and holds a market capitalization of CNY 17,115 million. However, it faces financial hurdles, including a low return on capital employed and a high debt-to-equity ratio, which may impact its long-term growth prospects.